Prospective Study of TW in the Treatment of LN Type V With Gross Proteinuria

The requested reference [9a2f516fef88698421aa785239c6e7b422c53b0e] no longer exists in our database. It has been replaced by the current reference: [ef79fb3499bc49bca85e2a028f2049f6d5beb4c6]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The purpose of this study is to analyze the clinical effects and adverse reactions of tripterygium glycosides (TW) and CTX in LN-V patients with gross proteinuria.
Epistemonikos ID: 9dc037e21229aa04c207110613bb20b7445f24e3
First added on: May 05, 2024